Author:
McCarty Dennis,Gu Yifan,McIlveen John W.,Lind Bonnie K.
Funder
National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Olfson M, Wall M, Barry CL, Mauro C, Mojtabai R. Impact of Medicaid expansion on coverage and treatment of low-income adults with substance use disorders. Health Aff. 2018;37(8):1208–15.
2. Feder KA, Mojtabai R, Krawczyk N, Young AS, Kealhofer M, Tormohlen KN, et al. Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care Act. Drug Alcohol Depend. 2017;179:271–4.
3. Wen H, Hockenberry JM, Borders TF, Druss BG. impact of Medicaid expansion on Medicaid-covered utilization of buprenorphine for opioid use disorder treatment. Med Care. 2017;55(4):336–41.
4. Oregon Health Authority Public Health Division. Prescribing and Overdose Data for Oregon Salem, Oregon: Oregon Health Authority; 2019.
https://www.oregon.gov/oha/ph/preventionwellness/substanceuse/opioids/pages/data.aspx
.
5. Penfold RB, Zhang F. Use of interrupted time series analysis in evaluating health care quality improvements. Acad Pediatr. 2013;13(13):S38–44.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献